Owais Tirmizi, MD Resident Physician in Psychiatry, University of Texas Southwestern Medical Center at Austin, Austin, TX, University of Texas Southwestern Medical Center, Dallas, TX Ahmad Raza, MD Professor of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX Kenneth Trevino, PhD Postdoctoral Fellow, Neurostimulation Research Lab, University of Texas Southwestern Medical Center, Dallas, TX Mustafa M. Husain, MD Professor of Psychiatry, Neurology, and Internal Medicine, Head of ECT Services, Director, Neurostimulation Research Lab, Chief, Geriatric Psychiatry Division, University of Texas Southwestern Medical Center, Dallas, TX
Leiknes KA, Jarosh-von Schweder L, Høie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2012;2(3):283-344.
Manka MV, Beyer JL, Weiner RD, et al. Clinical manual of electroconvulsive therapy. Arlington, VA: American Psychiatric Publishing; 2010.
Drug Brand Names
Esmolol • Brevibloc
Etomidate • Amidate
Glycopyrrolate • Robinul
Ketorolac • Toradol
Labetalol • Normodyne, Trandate
Methohexital • Brevital
Nicardipine • Cardene
Succinylcholine • Anectine
Disclosures
Dr. Husain receives grant or research support from Brainsway, Cyberonics, MagStim, NARSAD, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institute on Drug Abuse, NeoSync, Neuronetics, St. Jude Medical, and the Stanley Foundation.
Drs. Raza, Tirmizi, and Trevino report no relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
